Albert Bourla is a father of two children; a daughter and a son but their identity is unknown.
Advertisement
He is a Greek-American veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer’s divisions. Prior to becoming chief executive officer, Bourla served as chief operating officer.
Bourla was born and raised in Thessaloniki, Greece.
He earned a doctorate in the biotechnology of reproduction at Aristotle University of Thessaloniki’s Veterinary School in 1985.
Advertisement
![](https://abtc.ng/wp-content/uploads/2022/09/albert-bourla.jpg)
Bourla left Greece with his wife when he was 34 after a promotion within Pfizer and since then he has lived in seven different cities, in four different countries.
From 2010 to 2013, Bourla served as president and general manager of Pfizer’s Established Products Business Unit.
Bourla became Pfizer’s chief operating officer (COO) on January 1, 2018, overseeing the company’s drug development, manufacturing, sales, and strategy.
In 2020, Bourla pushed Pfizer employees for the fast development of a COVID-19 vaccine in partnership with German company BioNTech, making sure it is safe and effective.
Bourla was awarded the 2022 Genesis Prize for his leadership in the development of the Pfizer–BioNTech COVID-19 vaccine.
Leave a Reply